Novel ABCD1 Variants in X-Linked Adrenoleukodystrophy

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• X-linked adrenoleukodystrophy (X-ALD) is a severe neurodegenerative disorder.
• It is caused by mutations in the ABCD1 gene, affecting very long-chain fatty acid metabolism.
• Understanding the genetic basis is crucial for diagnosis and potential therapies.

Purpose of the Study:

• To characterize the clinical features and genetic findings in a cohort of 17 X-ALD patients.
• To identify and functionally validate novel ABCD1 gene mutations.
• To correlate genotype with phenotype and protein dysfunction in X-ALD.

Main Methods:

• Genetic analysis of 17 X-ALD patients to identify ABCD1 gene variants.
• Sequencing and variant analysis to detect mutations.
• Functional assays to assess protein pathogenicity and subcellular localization.

Main Results:

• Fifteen variants in the ABCD1 gene were identified in the 17 patients.
• Five novel mutations (c.700dupC, c.743G>A, c.1469_1471delTGG, c.1577C>A, c.1658T>C) were reported for the first time in X-ALD.
• Functional analysis confirmed the pathogenicity of these novel variants, with one mutant protein being undetectable due to mRNA degradation.

Conclusions:

• This study expands the known mutation spectrum of X-ALD.
• The findings enhance the clinical profile of X-ALD patients.
• A potential link between the degree of protein dysfunction and disease severity is suggested.